Prime Medicine Inc.

NASDAQ: PRME
Share price (12/23/24): $2.81
Market cap (12/23/24): $369 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Gottesdiener Keith Michael

Brudnick Richard

ARCH Venture Fund XII, L.P.

News Filter

Reports Third Quarter 2024 Financial Results and Provides Business Updates

Presents in Vivo Proof-Of-Concept Data Highlighting Interim Preclinical Advances in Its Wilson’s Disease Program and the Broad Potential of Its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Announces Strategic Research Collaboration and License Agreement With Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies

Reports Second Quarter 2024 Financial Results and Provides Business Updates

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC